Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05176418Phase 1Completed
Phase 1, randomised trial of nicotine in nicotine dependence (2 arms), sponsored by Yale University. Primary endpoint: Drug Effects Questionnaire mean score at 5 years. Started Sep 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05176418.